Pfizer COVID-19 vaccine could be available for children under 5 as soon as next month: report

Pfizer and BioNTech plan to submit a request for emergency use authorization for their COVID-19 vaccine in children six months to 5 years old as soon as Tuesday, which would set the vaccine up to be approved for young children in the coming weeks, the Washington Post reports.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.